Trillium Therapeutics Inc.

CIK 1616212 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Trillium Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Nov 29, 202115-12B0001104659-21-144076
Nov 19, 202140001104659-21-141738
Nov 19, 202140001104659-21-141747
Nov 19, 202140001104659-21-141739
Nov 19, 2021EFFECT9999999995-21-004415
Nov 19, 202140001104659-21-141749
Nov 19, 202140001104659-21-141742
Nov 19, 202140001104659-21-141740
Nov 19, 202140001104659-21-141748
Nov 19, 202140001104659-21-141751
Nov 19, 202140001104659-21-141741
Nov 19, 202140001104659-21-141750
Nov 19, 2021EFFECT9999999995-21-004414
Nov 19, 2021SC 13D/A0001072613-21-000655
Nov 19, 202140001209191-21-065762
Nov 19, 202140001104659-21-141743
Nov 19, 202140001104659-21-141746
Nov 19, 202140001104659-21-141737
Nov 17, 2021POSASR0001104659-21-140542
Nov 17, 202125-NSE0001354457-21-001345
Nov 17, 2021S-8 POS0001104659-21-140547
Nov 17, 2021POS AM0001104659-21-140539
Nov 17, 2021POS AM0001104659-21-140540
Nov 17, 2021S-8 POS0001104659-21-140548
Nov 17, 20218-K0001104659-21-140375